Cerebrospinal fluid levels of hexamethylmelamine and N-demethylated metabolites

Cancer Treat Rep. 1981 Mar-Apr;65(3-4):350-1.
No abstract available

Publication types

  • Case Reports
  • Clinical Trial

MeSH terms

  • Altretamine / cerebrospinal fluid*
  • Altretamine / metabolism
  • Altretamine / therapeutic use
  • Central Nervous System / drug effects
  • Clinical Trials as Topic
  • Drug Evaluation
  • Female
  • Humans
  • Middle Aged
  • Nervous System Neoplasms / drug therapy
  • Time Factors
  • Triazines / cerebrospinal fluid*

Substances

  • Triazines
  • Altretamine